Table of Content

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary research respondent, By Region
2.5. Assumption & Limitation

3. Executive Summary

4. Global Biomarker market Industry Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraint
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Company Market Share Analysis, 2019
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Intensity of Rivalry
4.7. Impact of COVID 19

5. Global Biomarker market Overview
5.1. Market Size & Forecast by Value, 2016-2026
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.1.1. Consumables
5.2.1.2. Service
5.2.2. By Type
5.2.2.1. Safety
5.2.2.2. Efficacy
5.2.2.3. Validation
5.2.3. By Disease Indication
5.2.3.1. Cancer
5.2.3.2. Cardiovascular Disorders
5.2.4. By Application
5.2.4.1. Diagnostics Development
5.2.4.2. Drug Discovery and Development
5.2.4.3. Disease-Risk
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific
5.2.5.4. Latin America
5.2.5.5. Middle East & Africa

6. North America Biomarker Market
6.1. Market Size & Forecast by Value, 2016-2026
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Disease Indication
6.2.4. By Application
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada

7. Europe Biomarker market
7.1. Market Size & Forecast by Value, 2016-2026
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Disease Indication
7.2.4. By Application
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. United Kingdom
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. Rest of Europe

8. Asia Pacific Biomarker Market
8.1. Market Size & Forecast by Value, 2016-2026
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Disease Indication
8.2.4. By Application
8.2.5. By Country
8.2.5.1. India
8.2.5.2. China
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Rest of Asia Pacific

9. Latin America Biomarker Market
9.1. Market Size & Forecast by Value, 2016-2026
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1.1. By Product
9.2.1.2. By Type
9.2.1.3. By Disease Indication
9.2.1.4. By Application
9.2.1.5. By Country
9.2.1.5.1. Brazil
9.2.1.5.2. Mexico
9.2.1.5.3. Rest of Latin America

10. Middle East & Africa Biomarker Market
10.1. Market Size & Forecast by Value, 2016-2026
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1.1. By Product
10.2.1.2. By Type
10.2.1.3. By Disease Indication
10.2.1.4. By Application
10.2.1.5. By Country
10.2.1.5.1. Saudi Arabia
10.2.1.5.2. UAE
10.2.1.5.3. South Africa
10.2.1.5.4. Rest of Middle East & Africa

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
11.1. Qiagen N.V.
11.2. Thermo Fisher Scientific Inc.
11.3. F. Hoffmann-La Roche Ltd,
11.4. PerkinElmer Inc.,
11.5. Merck KGaA,
11.6. Bio-Rad Laboratories,
11.7. Abbott Laboratories,
11.8. EKF Diagnostics
11.9. Enzo Biochem Inc.
11.10. Meso Scale Diagnostics, LLC
11.11. Signosis,
11.12. Other Prominent Players
* Financial details in case of unlisted companies will be available as per data availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.